|
|
|
市場調查報告書
中國的動物用疫苗產業報告:2010∼2011年
China Animal Vaccine Industry report, 2010-2011
|
中國的動物用疫苗產業報告:2010∼2011年 是由出版商ResearchInChina在2011年08月所出版的。
這份英文市場調查報告書包含86 Pages 價格從美金2000起跳。
中國的動物用疫苗市場正急速成長。2006∼2010年市場維持平均最大成長率13.6％，2010年達到75億元，與去年同期相比增加21.0％。一般認為藉由擴大增加動物傳染病的資本和動物疫苗接種的強制執行，以及加強中國的禽畜業標準化，將有助於提高中國的動物用疫苗產業未來的成長率。
本報告提供中國的動物用疫苗產業的相關調查，營運環境，發展情形，市場規模，需求與供給，競爭，進出口及發展預測的相關分析，中國主要的動物用疫苗製造商發展預測與優點彙整，為您概述為以下內容。
第1章 動物用疫苗概要
- 動物用疫苗的定義及分類
- 動物用生物製品的定義及分類
- 產業鏈
第2章 動物用疫苗產業的營運環境
第3章 中國的動物用疫苗產業
- 概要
- 市場規模
- 需求與供給
- 市場競爭
- 進出口
- 發展預測
第4章 中國的疫苗市場區隔
第5章主要製造商
- CAHIC
- Jinyu Group
- Tecon
- Ningbo Tech-Bank
- Shenghua Biok
- Huasun Group
- Harbin Pharmaceutical Group
- Tianjin Ringpu Bio-Technology
- Guandong Dahuanong Animal Health Products
- 中國的外國製造商
This report
- Analyzes the status quo of China animal vaccine industry & market.
- Focuses on the human vaccine market segments in China, including Swine
Vaccines and Poultry Vaccines
- Highlights the operation of major vaccine manufacturers in China.
Abstract
China animal vaccine industry has been fast-growing. The market maintained an
average annual growth rate up to 13.6% in 2006-2010, and reached around RMB
7.5 billion in 2010, up 21.0% YoY. With the increase of the state investment
in animal epidemic funds, the expansion of compulsory immunization against
animal epidemics and immunization scope as well as the strengthening of China
livestock breeding industry standardization, China animal vaccine industry is
expected to continue to maintain a relatively high growth momentum in future.
Although there are nearly 60 animal vaccine manufacturers in China, the market
share is concentrated in the hands of a few enterprises. CAHIC, YebioQD,
Guangdong DahuanongAnimal Health Products, Teconand Chengdu Tech-Bank are
representatives of China animal vaccine industry, accounting for a market
share of 37.4%. Sales of these companies mainly come from the government
procurement of compulsory vaccines, wherein, the revenue from government
compulsory vaccines accounted for 88% of the total animal vaccine revenue of
CAHIC in 2010.
According to China' s compulsory immunization plan against animal epidemics in
recent three years, China not only expands the application scope of the
existing animal immunization products, but also attaches great importance to
the upgrading of animal vaccine products at the same time. The applications of
high-performance passage cell-derived vaccine, synthesis peptide vaccine, etc.
are gradually being expanded, e.g., Classical Swine Fever Vaccine, Live Cell
Line Origin) expanded its application coverage from eight provinces in 2010 to
sixteen provinces in 2011.
However, due to the high requirements on technology and equipment from passage
cell-derived vaccine, synthesis peptide vaccine, etc., there are limited
manufacturers available right now. Although CAHIC, Tecon, etc all start their
layout in the field of Classical Swine Fever Vaccine, Live (Cell Line Origin),
Guangdong WinsunBio-pharmaceutical is still the major supplier in present
market. Tecon, Shanghai Shenlian, CAHIC, etc involve in production and sales
of synthesis peptide vaccine, but CAHIC produces synthesis peptide vaccine by
purchasing antigen from Shanghai Shenlian.
In recent year, the scope of China animal compulsory vaccination is being
gradually expanded. Constrained by economic conditions, the compulsory
immunization against animal epidemics currently only contains five kinds of
Epidemics of Class I, while there are about 17 kinds of Epidemic of Class I in
China and other epidemics lead to greater risk as well. With the increasing
recognition of animal epidemic prevention and control from breeding
enterprises and individuals, the future demand for conventional self-pay
vaccine will be further enhanced. As China livestock breeding relies mainly on
raising pig and poultry, Newcastle disease vaccine and porcine
circovirusvaccine will be two conventional vaccines with pretty good market
prospects.
Table of Contents
1. Overview of Animal Vaccine
- 1.1 Definition & Classification of Animal Vaccines
- 1.2 Definition & Classification of Animal Biological Products
- 1.3 Industry Chain
2. Operating Environment for Animal Vaccine Industry
- 2.1 Macro Environment
- 2.2 Policy Environment
- 2.3 Social Environment
- 2.4 International Environment
- 2.4.1 Market Scale
- 2.5 Overview of Vaccine Market
3. Development of Animal Vaccine Industry in China
- 3.1 Overview
- 3.2 Market Scale
- 3.3 Supply & Demand
- 3.4 Market Competition
- 3.5 Import and Export
- 3.5.1 Export
- 3.5.2 Import
- 3.6 Development Prospect
4. Animal Vaccine Market Segments in China
- 4.1 Swine Vaccines
- 4.1.1 Classical Swine Fever Vaccine
- 4.1.2 Pig Foot and Mouth Disease Vaccine
- 4.1.3 PRRS Vaccine
- 4.1.4 Porcine CircovirusVaccine
- 4.2 Poultry Vaccines
- 4.2.1 Newcastle Disease Vaccine
- 4.3 Cattle & Sheep Vaccines
- 4.4 Pet Vaccines
5. Key Enterprises
- 5.1 CAHIC
- 5.1.1 Profile
- 5.1.2 Operation
- 5.1.3 Animal Vaccine Business
- 5.1.4 Development Prospect & Advantages of Animal Vaccine Business
- 5.2 JinyuGroup
- 5.2.1 Profile
- 5.2.2 Operation
- 5.2.3 Animal Vaccine Business
- 5.2.4 Development Prospect & Advantages of Animal Vaccine Business
- 5.3 Tecon
- 5.3.1 Profile
- 5.3.2 Operation
- 5.3.3 Animal Vaccine Business
- 5.3.4 Development Prospect of Animal Vaccine Business
- 5.4 Ningbo Tech-Bank
- 5.4.1 Profile
- 5.4.2 Operation
- 5.4.3 Chengdu Tech-Bank (formerly Chengdu Jinghua)
- 5.5 ShenghuaBiok
- 5.5.1 Profile
- 5.5.2 Operation
- 5.5.3 YebioQD
- 5.6 HuasunGroup
- 5.6.1 Profile
- 5.6.2 Operation
- 5.6.3 Sichuan Huasun
- 5.7 Harbin Pharmaceutical Group
- 5.7.1 Profile
- 5.7.2 Status Quo & Prospect of Animal Vaccine Business
- 5.8 Tianjin RingpuBio-technology
- 5.8.1 Profile
- 5.8.2 Operation
- 5.8.3 Status Quo & Prospect of Animal Vaccine Business
- 5.9 Guangdong DahuanongAnimal Health Products
- 5.9.1 Profile
- 5.9.2 Operation
- 5.9.3 Status Quo & Prospect of Animal Vaccine Business
- 5.10 Foreign Enterprises in China
- 5.10.1 Merial
- 5.10.2 Boehringer-Ingelheim
- 5.10.3 Bayer
- 5.10.4 Novartis
- 5.10.5 Pfizer
Selected Charts
- Animal Vaccine Types and Characteristics
- Animal Vaccine Industry Chain
- Amount of Livestock on Hand in China, 2005-2010
- Classification of Animal Disease
- China' s GDP Growth Rate, 2007-2011Q2
- Major Policies Related to Animal Vaccine Industry, As of 2010
- China' s Meat, Poultry & Egg and Milk Output, 2007-2010
- Global Animal Vaccine Market Scale, 2004 & 2008-2010
- Vaccine Sales of Global Top 5 Vaccine Manufacturers, 2007-2010
- Main Mergers & Acquisitions in the Vaccine Industry Worldwide,
2005-Apr.2011
- Market Size of Human Vaccine and Animal Vaccine in China, 2007-2010
- EPI Vaccine Varieties in China, 2010
- Gross Margin of Major Vaccine Manufacturers in China, 2007-2010
- Mandatory Animal Disease Immunization Programs of China, 2009-2011
- China' s Animal Vaccine Market Share by Category, 2009-2010
- China' s Animal Vaccine Industry Market Scale & Growth, 2006-2010
- Major Manufacturers of Animal Vaccines in China
- Production of China' s Key Animal Vaccine Manufacturers
- China' s Animal Vaccine Consumption Structure by Animal Species, 2009-2010
- China' s Animal Vaccination Program, 2011
- Market Shares of China' s Main Animal Vaccine Manufacturers by Sales, 2010
- Manufacturers of Government Procurement Vaccines, 2008-2010
- Compulsory Vaccination Products of Listed Animal Vaccine Companies, 2010
- China' s Animal Vaccine Export Volume, Value and Average Unit Price,
2007-2010
- China' s Animal Vaccine Oversea Market Distribution, 2010
- China' s Animal Vaccine Import Volume, Value and Average Unit Price,
2007-2010
- Origins of China' s Imported Animal Vaccines, 2010
- China' s Animal Vaccine Industry Development Driving Forces
- M & A of Animal Vaccine Enterprises in China, by Aug 2011
- China' s Pig Inventory and Slaughter Quantity, 2000-2010
- China' s Pig Vaccine Market Scale, 2008-2010
- China' s Pet Vaccine Suppliers
- Performance Comparison of China' s Various Hog Cholera Vaccines
- Designated FMD Vaccine Manufacturers and Their Market Shares, 2010
- PRRS Vaccine Prices
- China' s Poultry Vaccine Market Scale, 2008-2010
- Major Poultry Vaccine Varieties and Manufacturers in China
- Market Capacity of Newcastle Disease Vaccine and Market Share of Tianjin
RingpuBio-technology
- Cattle & Sheep Vaccine Market Scale, 2008-2010
- China' s Pet Vaccine Market Scale, 2008-2010
- Operating Revenue and Net Income of CAHIC, 2007-2011Q1
- Operating Revenue & Structure by Business of CAHIC, 2007-2010
- Operating Revenue of CAHIC by Region, 2008-2010
- Animal Vaccine Capacity Distribution of CAHIC
- Animal Vaccine Sales Volume by Category of CAHIC, 2007-2010
- Animal Vaccine Operating Income and Gross Margin of CAHIC, 2007-2010
- Operating Revenue and Net Income of JinyuGroup, 2007-2011Q1
- Operating Revenue & Structure by Business of JinyuGroup, 2007-2010
- Operating Income and Operating Margin of JinyuGroup, 2008-2010
- Operating Revenue by Region of JinyuGroup, 2008-2010
- Animal Vaccine Capacity Distribution of JinyuGroup
- Animal Vaccine Revenue and Gross Margin of JinyuGroup, 2007-2010
- R&D Advantages of JinyuGroup
- Operating Revenue and Net Income of Tecon, 2007-2011Q1
- Operating Revenue and Structure by Business of Tecon, 2007-2010
- Operating Income and Operating Margin of Tecon, 2008-2010
- Ratio of R&D Input to Operating Revenue of Tecon, 2007-2010
- Operating Revenue by Region of Tecon, 2008-2010
- Animal Vaccine Revenue and Gross Margin of Tecon, 2007-2010
- Progress of Animal Vaccine R&D of Tecon, As of 2010
- Operating Revenue and Net Income of Ningbo Tech-Bank, 2008-2011Q1
- Operating Revenue and Structure by Business of Ningbo Tech-Bank, 2008-2010
- Gross Margin by Product of Ningbo Tech-Bank, 2008-2010
- Operating Revenue and Operating Income of Chengdu Tech-Bank, 2008-2010
- Operating Revenue and Net Income of ShenghuaBiok, 2007-2011Q1
- Operating Revenue and Structure by Business of ShenghuaBiok, 2007-2010
- Operating Margin of ShenghuaBiok, 2007-2010
- Operating Revenue Structure of ShenghuaBiokby Region, 2008-2010
- Operating Revenue and Net Income of YebioQD, 2008-2010
- Operating Revenue and Net Income of HuasunGroup, 2007-2011Q1
- Operating Revenue and Structure by Business of HuasunGroup, 2008-2010
- Gross Margin by Business of HuasunGroup, 2007-2010
- Operating Revenue and Net Income of Sichuan Huasun, 2008-2010
- Operation of Harbin Pharmaceutical Group, 2008-2009
- Operating Revenue and Net Income of Tianjin RingpuBio-technology,
2008-2011H1
- Sales of Tianjin RingpuBio-technology by Product, 2008-2010
- Gross Margin of Tianjin RingpuBio-technology by Product, 2007-2010
- Sales Revenue from Governmental Tendering and Its ratio of Tianjin
RingpuBio-technology, 2008-2010
- R & D Input and Its Ratio to Operating Revenue of Tianjin
RingpuBio-technology, 2008-2010
- Animal Vaccine Revenue of Tianjin RingpuBio-technology by Product,
2007-2010H1
- Operating Revenue and Net Income of Guangdong DahuanongAnimal Health
Products, 2008-2011Q1
- Sales of Guangdong DahuanongAnimal Health Products by Product, 2008-2010
- Gross Margin of Guangdong DahuanongAnimal Health Products by Product,
2007-2010
- R & D Input and Its Ratio to Operating Revenue of Guangdong
DahuanongAnimal Health Products, 2008-2010
- Main Animal Vaccine Products of Guangdong DahuanongAnimal Health Products
- Vaccine Projects under R&D and Their Progress of DahuanongAnimal Health
Products, As of 2010
- Animal Vaccine Products of Boehringer-Ingelheimin China Market, As of 2010
|
 |
